The Poirazi lab is the recipient of and will coordinate a new FET-OPEN grant entitled “A smart, hybrid neural-silico-computo device for drug discovery (Acronym: NEUREKA). The program involves the development of a novel hybrid technology, whereby nanoelectrodes and sophisticated computational models of neuronal circuits are combined to readout and manipulate activity/connectivity in cultured neuronal networks of Alzheimer’s disease, with subcellular accuracy. The consortium includes, in addition to FORTH, the University of Padova (Italy), the University of Milan Bicocca (Italy), the Centre National de la Recherche Scientifique (CNRS in France) and the Maxwell Biosystems AG (Switzerland) as partners.
Related Posts
-
Congratulations to Dr. Panayiota Poirazi for her election as an honorary member of the Biological Society of Cyprus (B. S. C.)!
07/09/2023
-
Dendrify: a new framework for adding dendrites to spiking neural networks
13/01/2023
-
Long-range cortical inputs drive local dendritic spikes in hippocampal pyramidal neurons
13/01/2023